TriSalus Life Earnings Estimate

TLSI Stock   5.32  0.25  4.93%   
The next projected EPS of TriSalus Life is estimated to be -0.1633 with future projections ranging from a low of -0.19 to a high of -0.12. TriSalus Life's most recent 12-month trailing earnings per share (EPS TTM) is at -1.1. Please be aware that the consensus of earnings estimates for TriSalus Life Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
TriSalus Life is projected to generate -0.1633 in earnings per share on the 30th of September 2025. TriSalus Life earnings estimates show analyst consensus about projected TriSalus Life Sciences EPS (Earning Per Share). It derives the highest and the lowest estimates based on TriSalus Life's historical volatility. Many public companies, such as TriSalus Life, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing TriSalus Life's earnings estimates, investors can diagnose different trends across TriSalus Life's analyst sentiment over time as well as compare current estimates against different timeframes. The current Gross Profit is estimated to decrease to about 16.1 M. The current Pretax Profit Margin is estimated to decrease to -1.07Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TriSalus Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

TriSalus Life Earnings Estimation Breakdown

The calculation of TriSalus Life's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of TriSalus Life is estimated to be -0.1633 with the future projection ranging from a low of -0.19 to a high of -0.12. Please be aware that this consensus of annual earnings estimates for TriSalus Life Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.26
-0.19
Lowest
Expected EPS
-0.1633
-0.12
Highest

TriSalus Life Earnings Projection Consensus

Suppose the current estimates of TriSalus Life's value are higher than the current market price of the TriSalus Life stock. In this case, investors may conclude that TriSalus Life is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and TriSalus Life's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 30th of September 2025Current EPS (TTM)
880.86%
-0.265
-0.1633
-1.1

TriSalus Life Earnings History

Earnings estimate consensus by TriSalus Life Sciences analysts from Wall Street is used by the market to judge TriSalus Life's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only TriSalus Life's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

TriSalus Life Quarterly Gross Profit

7.67 Million

The current Retained Earnings is estimated to decrease to about (293.5 M). The current Earnings Yield is estimated to decrease to -0.26 The current Common Stock Shares Outstanding is estimated to decrease to about 22.8 M.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of TriSalus Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2.045.328.60
Details
Intrinsic
Valuation
LowRealHigh
3.336.619.89
Details
Naive
Forecast
LowNextHigh
1.915.188.46
Details
8 Analysts
Consensus
LowTargetHigh
10.2911.3112.56
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of TriSalus assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards TriSalus Life. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving TriSalus Life's stock price in the short term.

TriSalus Life Earnings per Share Projection vs Actual

Actual Earning per Share of TriSalus Life refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering TriSalus Life Sciences predict the company's earnings will be in the future. The higher the earnings per share of TriSalus Life, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

TriSalus Life Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as TriSalus Life, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of TriSalus Life should always be considered in relation to other companies to make a more educated investment decision.

TriSalus Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact TriSalus Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-05-15
2025-03-31-0.1967-0.265-0.068334 
2025-03-27
2024-12-31-0.35-0.4-0.0514 
2024-11-14
2024-09-30-0.365-0.397-0.032
2024-08-15
2024-06-30-0.46-0.210.2554 
2024-05-15
2024-03-31-0.65-0.60.05
2023-12-31
2023-12-31-0.69-1.56-0.87126 
2023-03-22
2022-12-310-0.01-0.01
2022-11-10
2022-09-3000.020.02
2022-08-10
2022-06-3000.080.08
2022-05-11
2022-03-3100.090.09
2022-03-03
2021-12-3100.090.09
2021-11-12
2021-09-3000.060.06
2021-08-16
2021-06-3000.010.01
2021-06-28
2021-03-310-0.01-0.01

About TriSalus Life Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of TriSalus Life earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current TriSalus Life estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as TriSalus Life fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-279.5 M-293.5 M
Earnings Yield(0.25)(0.26)
Price Earnings Ratio(4.00)(4.19)
Price Earnings To Growth Ratio 0.09  0.09 

Currently Active Assets on Macroaxis

When determining whether TriSalus Life Sciences is a strong investment it is important to analyze TriSalus Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TriSalus Life's future performance. For an informed investment choice regarding TriSalus Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TriSalus Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.10)
Revenue Per Share
1.207
Quarterly Revenue Growth
0.42
Return On Assets
(0.86)
Return On Equity
(4.96)
The market value of TriSalus Life Sciences is measured differently than its book value, which is the value of TriSalus that is recorded on the company's balance sheet. Investors also form their own opinion of TriSalus Life's value that differs from its market value or its book value, called intrinsic value, which is TriSalus Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TriSalus Life's market value can be influenced by many factors that don't directly affect TriSalus Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TriSalus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.